Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Solid Tumor × encorafenib × Clear all

Sponsor

Conditions

Melanoma 13 Neoplasm Metastasis 4 Colorectal Neoplasms 4 Neoplasms 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Solid Tumors Harboring a BRAF V600 Mutation 1 Skin Neoplasms 1 Skin Diseases 1 Pancreatic Neoplasms 1 Lymphatic Metastasis 1 Hematologic Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Astrocytoma 1 Advanced BRAF Mutant Cancers 1

Interventions

Nivolumab 4 pertuzumab 2 pembrolizumab 2 durvalumab 2 Paclitaxel 2 Docetaxel 2 Capecitabine 2 ulocuplumab 1 tremelimumab 1 tazarotene 1 talazoparib 1 romiplostim 1 pexidartinib 1 pamiparib 1 onartuzumab 1 magrolimab 1 entrectinib 1 cobimetinib 1 atezolizumab 1 Sunitinib 1 Rifampin 1 Ramucirumab 1 Radiosurgery 1 N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 1 Midazolam 1 MK-4166 1 LY3022855 1 LY2510924 1 LY-2157299 1 Itraconazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡